Strategic Analysis Of The Global Immunohematology Market 2024 - 2033

August 15, 2024 12:45 AM AEST | By EIN Presswire
 Strategic Analysis Of The Global Immunohematology Market 2024 - 2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, August 14, 2024 /EINPresswire.com/ -- from $2.34 billion in 2023 to $2.49 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.3%. This expansion is driven by advancements in blood transfusion science, the rising prevalence of blood disorders, the growth of blood banks, government initiatives for blood safety, a surge in surgical procedures, and heightened awareness of transfusion-related risks. The market is projected to reach $3.04 billion by 2028, at a CAGR of 5.1%, fueled by factors such as increasing demand for point-of-care testing, the emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety.

Driving Factors Behind Market Growth
The growth of the immunohematology market can be largely attributed to several key factors. The increasing demand for point-of-care testing, advancements in novel blood products, and expansion of healthcare infrastructure are pivotal. Additionally, genetic testing for blood compatibility and regulatory support for blood safety are crucial in propelling the market forward. The aging population also plays a significant role, as immunohematology is critical for addressing age-related transfusion needs and ensuring safe blood product use. The United States Census Bureau reported an increase in the median age to 38.9 years in 2022, highlighting the ongoing demographic shift that drives demand for immunohematology solutions.

Explore comprehensive insights into the global immunohematology market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=10295&type=smp

Major Companies and Technological Advancements
Leading companies in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, and Grifols S.A., among others. These companies are at the forefront of technological advancements, focusing on developing innovative solutions to maintain their competitive edge. For example, Ortho Clinical Diagnostics launched new capabilities for its Immediate Spin Crossmatch (ISXM) system for ORTHO VISION and ORTHO VISION MAX Analyzers in October 2021. This system streamlines and automates immunohematology testing, enhancing the efficiency of blood transfusions by identifying ABO blood type incompatibility.

Emerging Trends in Immunohematology
Key trends shaping the immunohematology market include the adoption of automation and high-throughput systems, advancements in molecular blood typing methods, and the development of new antibody detection techniques. Patient blood management programs, integration of AI in analysis, and telemedicine integration are also becoming prominent. These trends reflect the industry's ongoing efforts to enhance the precision and efficiency of blood testing and transfusion processes.

Market Segmentation
The immunohematology market is segmented as follows:
1. By Product: Analyzers and Systems, Reagents
2. By Technology: Biochips, Erythrocyte-Magnetized Technology (EMT), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3. By Disease: Blood-Related Diseases, HIV, Hepatitis
4. By Application: Pretransfusion Testing, Investigation of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte and Platelet Serology
5. By End User: Blood Banks, Diagnostic and Reference Laboratories, Hospitals, Academic and Research Institutes

Regional Insights: North America Leading the Market
North America was the largest region in the immunohematology market in 2023. However, Asia-Pacific is anticipated to be the fastest-growing region during the forecast period. This growth is driven by expanding healthcare infrastructure and increasing investment in medical technologies in the region.

Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunohematology Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Immunohematology Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on immunohematology market size, immunohematology market drivers and trends, immunohematology market major players, competitors' revenues, market positioning, and market growth across geographies. The immunohematology market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Implantable Cardiac Rhythm Management Device Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Implantable Defibrillators Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-defibrillators-global-market-report

Immunodiagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.